Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review

The incidence of gastrointestinal perforations among rheumatoid arthritis patients

(2010) Jeffrey R. Curtis et al.   ARTHRITIS AND RHEUMATISM

Tocilizumab: Therapy and safety management

(2010) Thao Pham et al.   JOINT BONE SPINE

Averting inflammation by targeting the cytokine environment

(2010) Manfred Kopf et al.   NATURE REVIEWS DRUG DISCOVERY

Transmembrane TNF- : structure, function and interaction with anti-TNF agents

(2010) T. Horiuchi et al.   RHEUMATOLOGY

Th17 cytokines in mucosal immunity and inflammation

(2010) Lokesh Guglani et al.   Current Opinion in HIV and AIDS

A Novel Composite Endpoint to Evaluate the Gastrointestinal (GI) Effects of Nonsteroidal Antiinflammatory Drugs Through the Entire GI Tract

(2009) F. K. L. CHAN et al.   JOURNAL OF RHEUMATOLOGY

Hip involvement in ankylosing spondylitis

(2009) Xenofon Baraliakos et al.   RHEUMATOLOGY

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

(2008) P. Emery et al.   ANNALS OF THE RHEUMATIC DISEASES

Incidence of perforated diverticulitis and risk factors for death in a UK population

(2008) C. R. Morris et al.   BRITISH JOURNAL OF SURGERY

Perforated colonic diverticular disease: the importance of NSAIDs, opioids, corticosteroids, and calcium channel blockers

(2008) Kristoffer Piekarek et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Moderne Therapie der Divertikelkrankheit

(2008) L. Leifeld et al.   INTERNIST